NG Biotech is a French innovative biotech company developing & manufacturing novel in vitro diagnostic tools for Therapy Monitoring at the Point of Care (Onsite).  NG Biotech patented platform is rapid, mobile and connected; it allows to analyze a direct sample as finger prick blood in 5 minutes and to communicate the result.

The company, founded by pioneers of the rapid test industry, has developed a proprietary patented immunoassay platform enabling the development of quantitative and multiplex point of care diagnostics. The platform can be adapted to detect or monitor  any kind of antibody, antigen, pathogen, parasite, hormone , drug… The tests are then associated to wireless mobile readers. Results are obtained in few minutes from a single drop of blood (or any other type of sample) and can be communicated to any server or cloud for data sharing and management.

More About Us